The Danish pharma company announced this morning that it will roll out what its calling the first multimonth subscription program for an FDA-approved obesity drug, offering Wegovy at a fixed monthly price that features savings of up to $1,200 a year for self-pay patients
It also covers sexual health and longevity treatments
It costs about $1000 per month, or $12,000 a year, to take a drug like Ozempic or Mounjaro
Oral Wegovy Side Effects and Safety Common oral Wegovy side effects include nausea, mild diarrhea, decreased appetite, and stomach discomfort
J Asian Nat Prod Res
The Triple-Receptor Frontier of Metabolic Therapy Retatrutide is an investigational synthetic peptide that activates three metabolic receptors simultaneously: GLP-1, GIP, and glucagon